Evidence map›Paper›PMID 27742221›Full record

ArticleVaccine2016

Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes.

Nicola Logan, William G Dundon, Adama Diallo, Michael D Baron, M James Nyarobi, Sarah Cleaveland, Julius Keyyu, Robert Fyumagwa, Margaret J Hosie, Brian J Willett

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Viruses · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Nicola LoganMRC-University of Glasgow Centre for Virus Research, Garscube Estate, Glasgow G61 1QH, UK. Electronic address: nicola.logan@glasgow.ac.uk.
William G DundonAnimal Production and Health Laboratory, International Atomic Energy Agency, Seibersdorf, Austria. Electronic address: W.Dundon@iaea.org.
Adama DialloAnimal Production and Health Laboratory, International Atomic Energy Agency, Seibersdorf, Austria. Electronic address: adama.diallo@cirad.fr.
Michael D BaronThe Pirbright Institute, Pirbright, Woking, Surrey GU24 0NF, UK. Electronic address: michael.baron@pirbright.ac.uk.
M James NyarobiBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity Animal Health and Comparative Medicine, University of Glasgow, Glasgow G12 8QQ, UK. Electronic address: nyarobijames@gmail.com.
Sarah CleavelandBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity Animal Health and Comparative Medicine, University of Glasgow, Glasgow G12 8QQ, UK. Electronic address: sarah.cleaveland@glasgow.ac.uk.
Julius KeyyuTanzania Wildlife Research Institute (TAWIRI), Arusha, Tanzania. Electronic address: julius.keyyu@gmail.com.
Robert FyumagwaTanzania Wildlife Research Institute (TAWIRI), Arusha, Tanzania. Electronic address: robert.fyumagwa@tawiri.or.tz.
Margaret J HosieMRC-University of Glasgow Centre for Virus Research, Garscube Estate, Glasgow G61 1QH, UK. Electronic address: margaret.hosie@glasgow.ac.uk.
Brian J WillettMRC-University of Glasgow Centre for Virus Research, Garscube Estate, Glasgow G61 1QH, UK. Electronic address: brian.willett@glasgow.ac.uk.
MRC University of Glasgow Centre for Virus Research · GBInternational Atomic Energy Agency · ATTanzania Wildlife Research Institute · TZGlasgow Centre for Population Health · GBThe Pirbright Institute · GBUniversity of Glasgow · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H009302/1Medical Research Council
6 · The paper itself

Abstract

The measurement of virus-specific neutralising antibodies represents the "gold-standard" for diagnostic serology. For animal morbilliviruses, such as peste des petits ruminants (PPRV) or rinderpest virus (RPV), live virus-based neutralisation tests require high-level biocontainment to prevent the accidental escape of the infectious agents. In this study, we describe the adaptation of a replication-defective vesicular stomatitis virus (VSVΔG) based pseudotyping system for the measurement of neutralising antibodies against animal morbilliviruses. By expressing the haemagglutinin (H) and fusion (F) proteins of PPRV on VSVΔG pseudotypes bearing a luciferase marker gene, neutralising antibody titres could be measured rapidly and with high sensitivity. Serological responses against the four distinct lineages of PPRV could be measured simultaneously and cross-neutralising responses against other morbilliviruses compared. Using this approach, we observed that titres of neutralising antibodies induced by vaccination with live attenuated PPRV were lower than those induced by wild type virus infection and the level of cross-lineage neutralisation varied between vaccinates. By comparing neutralising responses from animals infected with either PPRV or RPV, we found that responses were highest against the homologous virus, indicating that retrospective analyses of serum samples could be used to confirm the nature of the original pathogen to which an animal had been exposed. Accordingly, when screening sera from domestic livestock and wild ruminants in Tanzania, we detected evidence of cross-species infection with PPRV, canine distemper virus (CDV) and a RPV-related bovine morbillivirus, suggesting that exposure to animal morbilliviruses may be more widespread than indicated previously using existing diagnostic techniques.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCattleCross ReactionsDefective VirusesDistemper Virus, CanineDogsGoatsHEK293 CellsHumansMonitoring, ImmunologicPeste-des-Petits-RuminantsPeste-des-petits-ruminants virusRetrospective StudiesRinderpestAntibodies, NeutralizingAntibodies, ViralVaccines, AttenuatedViral VaccinesMorbillivirusNeutralising antibodyPeste des petits ruminantsPPRV, rinderpest, RPVSurveillance

Identifiers

PMID27742221
PMCPMC5084683
OpenAlexW2530673878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.